Published in PLoS One on August 12, 2013
Genistein attenuates glucocorticoid-induced bone deleterious effects through regulation Eph/ephrin expression in aged mice. Int J Clin Exp Pathol (2015) 0.79
Potential Effects of Phytoestrogen Genistein in Modulating Acute Methotrexate Chemotherapy-Induced Osteoclastogenesis and Bone Damage in Rats. Int J Mol Sci (2015) 0.78
Combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil causes trabecular bone loss, bone marrow cell depletion and marrow adiposity in female rats. J Bone Miner Metab (2015) 0.76
Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects? Int J Mol Sci (2017) 0.75
Osteoclast differentiation and activation. Nature (2003) 18.59
Acute lymphoblastic leukaemia. Lancet (2008) 8.54
Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab (2004) 8.36
Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med (2000) 5.02
Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest (2002) 3.29
Phyto-oestrogens and Western diseases. Ann Med (1997) 3.13
Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr (2000) 2.92
The pharmacology and clinical use of methotrexate. N Engl J Med (1983) 2.29
Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. J Bone Miner Res (1989) 1.87
RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. J Bone Miner Res (2004) 1.83
Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat (2004) 1.75
Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J Biol Chem (2006) 1.73
Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake. Am J Hematol (2008) 1.71
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res (2002) 1.69
Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital. Drug Saf (2009) 1.68
Bone and fat connection in aging bone. Curr Opin Rheumatol (2008) 1.58
Risks and benefits of bisphosphonates. Br J Cancer (2008) 1.57
Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer (1970) 1.56
The signaling adapter protein DAP12 regulates multinucleation during osteoclast development. J Bone Miner Res (2003) 1.52
Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems. Cancer (1976) 1.48
The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. J Periodontal Res (2004) 1.42
Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res (2003) 1.38
Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr (2003) 1.36
Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano) (1998) 1.26
The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. Endocrinology (2003) 1.22
Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database. Pediatr Blood Cancer (2007) 1.15
An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J (2007) 1.14
Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells. J Cell Physiol (2009) 1.14
Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot Essent Fatty Acids (2003) 1.13
An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption. Br J Pharmacol (2008) 1.13
Damage and recovery of the bone growth mechanism in young rats following 5-fluorouracil acute chemotherapy. J Cell Biochem (2006) 1.06
Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. J Cell Biochem (2011) 1.06
Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects. Bone (2007) 1.03
Augmentation of chemotherapy-induced cytokine production by expression of the platelet-activating factor receptor in a human epithelial carcinoma cell line. J Immunol (2004) 1.00
Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats. Reprod Toxicol (2001) 1.00
Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. Biochem Biophys Res Commun (2002) 0.98
Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling. J Cell Physiol (2013) 0.97
Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate. Br J Pharmacol (2009) 0.97
Dietary phyto-oestrogens and bone health. Proc Nutr Soc (2003) 0.96
The short- and long-term effects of methotrexate on the rat skeleton. Bone (1995) 0.96
Long-chain polyunsaturated fatty acids and the regulation of bone metabolism. Exp Biol Med (Maywood) (2007) 0.95
Genistein inhibits CCAAT/enhancer-binding protein beta (C/EBPbeta) activity and 3T3-L1 adipogenesis by increasing C/EBP homologous protein expression. Biochem J (2002) 0.95
Methotrexate osteopathy in patients with osteosarcoma. Radiology (1997) 0.94
Fractures in children treated with methotrexate for leukemia. Clin Orthop Relat Res (1977) 0.94
Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow. J Cell Physiol (2012) 0.93
Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats. Bone (2012) 0.93
The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats. Arthritis Rheum (1994) 0.93
Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation. Biol Pharm Bull (2003) 0.92
Protective actions of soy isoflavones and n-3 PUFAs on bone mass in ovariectomized rats. J Nutr Biochem (2005) 0.91
Genistein stimulates osteoblastic differentiation via p38 MAPK-Cbfa1 pathway in bone marrow culture. Acta Pharmacol Sin (2007) 0.91
Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia. J Pediatr (1989) 0.91
Methotrexate chemotherapy promotes osteoclast formation in the long bone of rats via increased pro-inflammatory cytokines and enhanced NF-κB activation. Am J Pathol (2012) 0.90
Effect of omega 3 polyunsaturated fatty acid ingestion on bone metabolism and osteoporosis. World Rev Nutr Diet (2001) 0.89
Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Saf (2001) 0.89
Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids. J Am Coll Nutr (2005) 0.88
Effects of etoposide and cyclophosphamide acute chemotherapy on growth plate and metaphyseal bone in rats. Cancer Biol Ther (2007) 0.87
Folinic acid attenuates methotrexate chemotherapy-induced damages on bone growth mechanisms and pools of bone marrow stromal cells. J Cell Physiol (2008) 0.87
Expression of proinflammatory cytokines and growth factors at the injured growth plate cartilage in young rats. Bone (2004) 0.87
Methotrexate-induced bone pain in childhood leukemia. Am J Dis Child (1973) 0.84
Effect of daidzin, genistin, and glycitin on osteogenic and adipogenic differentiation of bone marrow stromal cells and adipocytic transdifferentiation of osteoblasts. Acta Pharmacol Sin (2005) 0.84
Phytoestrogens directly inhibit TNF-α-induced bone resorption in RAW264.7 cells by suppressing c-fos-induced NFATc1 expression. J Cell Biochem (2011) 0.84
Incorporation of long-chain n-3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post-weanling Fischer 344 rats. Lipids (1997) 0.82
The role of caspases in methotrexate-induced gastrointestinal toxicity. Surgery (2001) 0.82
Differential effects of genistein, estradiol and raloxifene on rat osteoclasts in vitro. Pharmacol Rep (2005) 0.82
Effects of lifelong dietary exposure to genistein or nonylphenol on amphetamine-stimulated striatal dopamine release in male and female rats. Neurotoxicol Teratol (2002) 0.81
Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in female patients with rheumatoid arthritis. Clin Biochem (2009) 0.81
Lung function and serum concentrations of different cytokines in patients submitted to radiotherapy and intermediate/high dose chemotherapy for Hodgkin's disease. Anticancer Res (2002) 0.80
Protective role of n-3 lipids and soy protein in osteoporosis. Prostaglandins Leukot Essent Fatty Acids (2003) 0.80
Perinatal maternal dietary supplementation of ω3-fatty acids transiently affects bone marrow microenvironment, osteoblast and osteoclast formation, and bone mass in male offspring. Endocrinology (2012) 0.80
Combined effects of soy isoflavone and fish oil on ovariectomy-induced bone loss in mice. J Bone Miner Metab (2010) 0.80
Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity. J Pharmacol Exp Ther (2005) 0.79
Isoflavones and bone: animal and human evidence of efficacy. J Musculoskelet Neuronal Interact (2002) 0.79
Conjugated linoleic acid and bone biology. J Am Coll Nutr (2000) 0.79
Pattern of bone marrow regeneration following chemotherapy for acute myeloid leukemia. J Med (1987) 0.78
Do n-3 fatty acids prevent osteoporosis? Am J Clin Nutr (2007) 0.78
Comparison of bone mineral density among residents of a mountain village and a fishing village in Japan. J Orthop Surg (Hong Kong) (2003) 0.78
Bonistein (synthetic genistein), a food component in development for a bone health nutraceutical. J Physiol Pharmacol (2005) 0.76
[Influence of FOLFOX regimen on the immunologic function in patients with advanced colorectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi (2010) 0.76
Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. Immunity (2008) 1.77
Dietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model. J Cardiovasc Electrophysiol (2005) 1.55
Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair. J Cell Physiol (2008) 1.47
Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors. Proc Natl Acad Sci U S A (2008) 1.26
Cross-talk between Chk1 and Chk2 in double-mutant thymocytes. Proc Natl Acad Sci U S A (2007) 1.16
Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells. J Cell Physiol (2009) 1.14
Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. J Cell Biochem (2011) 1.06
Role of FGFs/FGFRs in skeletal development and bone regeneration. J Cell Physiol (2012) 1.04
TNF-alpha mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats. J Bone Miner Res (2006) 1.02
The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis. J Exp Med (2012) 1.02
Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling. J Cell Physiol (2013) 0.97
Intermittent PTH (1-34) injection rescues the retarded skeletal development and postnatal lethality of mice mimicking human achondroplasia and thanatophoric dysplasia. Hum Mol Genet (2012) 0.97
Dietary emu oil supplementation suppresses 5-fluorouracil chemotherapy-induced inflammation, osteoclast formation, and bone loss. Am J Physiol Endocrinol Metab (2012) 0.97
Lyprinol (stabilised lipid extract of New Zealand green-lipped mussel): a potential preventative treatment modality for inflammatory bowel disease. J Gastroenterol (2005) 0.96
Effect of lumbar 5 ventral root transection on pain behaviors: a novel rat model for neuropathic pain without axotomy of primary sensory neurons. Exp Neurol (2002) 0.95
Regulatory pathways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocorticoid therapy and radiotherapy. Am J Stem Cells (2012) 0.95
A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia. Hum Mol Genet (2012) 0.95
Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow. J Cell Physiol (2012) 0.93
Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats. Bone (2012) 0.93
Roles of neutrophil-mediated inflammatory response in the bony repair of injured growth plate cartilage in young rats. J Leukoc Biol (2006) 0.93
Oral administration of Lactobacillus plantarum K68 ameliorates DSS-induced ulcerative colitis in BALB/c mice via the anti-inflammatory and immunomodulatory activities. Int Immunopharmacol (2011) 0.91
Interaction of dietary zinc and intracellular binding protein metallothionein in postnatal bone growth. Bone (2009) 0.91
Crucial role for TNF receptor-associated factor 2 (TRAF2) in regulating NFκB2 signaling that contributes to autoimmunity. Proc Natl Acad Sci U S A (2011) 0.91
Docosahexaenoic acid-rich fish oil improves heart rate variability and heart rate responses to exercise in overweight adults. Br J Nutr (2008) 0.91
Methotrexate chemotherapy promotes osteoclast formation in the long bone of rats via increased pro-inflammatory cytokines and enhanced NF-κB activation. Am J Pathol (2012) 0.90
Masticatory motor pattern in the koala (Phascolarctos cinereus): a comparison of jaw movements in marsupial and placental herbivores. J Exp Zool A Ecol Genet Physiol (2010) 0.90
Preclinical studies on mesenchymal stem cell-based therapy for growth plate cartilage injury repair. Stem Cells Int (2011) 0.89
Potential roles of growth factor PDGF-BB in the bony repair of injured growth plate. Bone (2009) 0.88
The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro. Endocrinology (2013) 0.87
Prevention of bone growth defects, increased bone resorption and marrow adiposity with folinic acid in rats receiving long-term methotrexate. PLoS One (2012) 0.87
Expression of proinflammatory cytokines and growth factors at the injured growth plate cartilage in young rats. Bone (2004) 0.87
Lumbar 5 ventral root transection-induced upregulation of nerve growth factor in sensory neurons and their target tissues: a mechanism in neuropathic pain. Mol Cell Neurosci (2003) 0.87
The influence of therapeutic radiation on the patterns of bone marrow in ovary-intact and ovariectomized mice. PLoS One (2012) 0.86
The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss. J Cell Physiol (2012) 0.86
Salinomycin induces apoptosis via death receptor-5 up-regulation in cisplatin-resistant ovarian cancer cells. Anticancer Res (2013) 0.85
Application of autologous bone marrow derived mesenchymal stem cells to an ovine model of growth plate cartilage injury. Open Orthop J (2010) 0.85
Microarray expression analysis of genes and pathways involved in growth plate cartilage injury responses and bony repair. Bone (2012) 0.85
Regulation of bone morphogenetic protein signalling and cranial osteogenesis by Gpc1 and Gpc3. Bone (2013) 0.84
Injury responses and repair mechanisms of the injured growth plate. Front Biosci (Schol Ed) (2011) 0.83
Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats. Growth Horm IGF Res (2005) 0.83
Usefulness of a guiding sheath for fluoroscopic stent placement in patients with malignant gastroduodenal obstruction. Acta Radiol (2013) 0.83
Leukocyte numbers and function in subjects eating n-3 enriched foods: selective depression of natural killer cell levels. Arthritis Res Ther (2008) 0.82
Preconditioning selective ventral root injury promotes plasticity of ascending sensory neurons in the injured spinal cord of adult rats--possible roles of brain-derived neurotrophic factor, TrkB and p75 neurotrophin receptor. Eur J Neurosci (2009) 0.82
Roles of Wnt/β-catenin signalling pathway in the bony repair of injured growth plate cartilage in young rats. Bone (2012) 0.81
Different electromagnetic field waveforms have different effects on proliferation, differentiation and mineralization of osteoblasts in vitro. Bioelectromagnetics (2013) 0.81
Methotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children. J Biomed Biotechnol (2011) 0.81
Maternal omega-3 supplementation increases fat mass in male and female rat offspring. Front Genet (2011) 0.81
Expression of bone morphogenic proteins and receptors at the injured growth plate cartilage in young rats. J Histochem Cytochem (2006) 0.81
Upregulation of brain-derived neurotrophic factor in the sensory pathway by selective motor nerve injury in adult rats. Neurotox Res (2006) 0.81
Deregulation of the CXCL12/CXCR4 axis in methotrexate chemotherapy-induced damage and recovery of the bone marrow microenvironment. Int J Exp Pathol (2012) 0.81
Perinatal maternal dietary supplementation of ω3-fatty acids transiently affects bone marrow microenvironment, osteoblast and osteoclast formation, and bone mass in male offspring. Endocrinology (2012) 0.80
Icariin induces osteoblast differentiation and mineralization without dexamethasone in vitro. Planta Med (2013) 0.79
EGFL7 is expressed in bone microenvironment and promotes angiogenesis via ERK, STAT3, and integrin signaling cascades. J Cell Physiol (2015) 0.78
Methotrexate-induced bone marrow adiposity is mitigated by folinic acid supplementation through the regulation of Wnt/β-catenin signalling. J Cell Physiol (2015) 0.77
The potential role of VEGF-induced vascularisation in the bony repair of injured growth plate cartilage. J Endocrinol (2014) 0.77
Inhibition of protein kinase-D promotes cartilage repair at injured growth plate in rats. Injury (2013) 0.77
Widespread differential maternal and paternal genome effects on fetal bone phenotype at mid-gestation. J Bone Miner Res (2014) 0.76
Dietary zinc and metallothionein on small intestinal disaccharidases activity in mice. World J Gastroenterol (2011) 0.75
Fish oil in comparison to folinic acid for protection against adverse effects of methotrexate chemotherapy on bone. J Orthop Res (2013) 0.75
Protective effects of tripterygium glycoside-loaded solid lipid nanoparticles on male reproductive toxicity in rats. Arzneimittelforschung (2011) 0.75
The Effects of an Empowerment Intervention on Renal Transplant Recipients: A Randomized Controlled Trial. J Nurs Res (2016) 0.75
An immunomodulator used to protect young in the pouch of the Tammar wallaby, Macropus eugenii. FEBS J (2005) 0.75
Potential roles of metallothioneins I and II in protecting bone growth following acute methotrexate chemotherapy. J Chemother (2013) 0.75
Exploring the relationship between personality features and teaching self-efficacy in clinical nursing preceptors. J Nurs Res (2014) 0.75
[Effects of fluvastatin on the levels of C-reactive protein and lipids in patients with hyperlipidemia]. Di Yi Jun Yi Da Xue Xue Bao (2002) 0.75
Osteoporosis. Int J Endocrinol (2013) 0.75
[Coagulative and fibrinolytic changes in patients with essential hypertension and the effect of sustained-release nifedipine]. Di Yi Jun Yi Da Xue Xue Bao (2002) 0.75